Salivary sex-hormone panel (estradiol / estriol / progesterone / testosterone / DHEA)

ND-recommended test reviewed: salivary sex-hormone panel (estradiol/estriol/progesterone/testosterone/DHEA).
Indications reviewed: no validated diagnostic indication for this panel identified.
Not ordered. Rationale discussed: salivary hormone assays are not standardized and lack a validated reference range for diagnosis or dosing. Ref: NAMS 2022 Hormone Therapy Position Statement.
Patient informed test available privately via ND. Patient given info page: https://labs.ajaxharwoodclinic.com/salivary-hormone-panel/patient
Revisit if: symptoms suggest a specific, testable condition; order the targeted serum test instead.

Indicated when

None recorded.

Not indicated when

• —Any use to diagnose a sex-hormone deficiency or excess, guide hormone therapy dosing, or assess 'hormone balance': salivary assays for these hormones are not standardized and are considered unreliable [1]
• —Investigating menopausal, perimenopausal, or 'estrogen dominance' symptoms as a stand-alone panel

Why not

The North American Menopause Society's 2022 position statement states plainly that 'salivary and urine hormone testing to determine dosing are unreliable and not recommended,' citing differences in pharmacokinetics, diurnal variation, and interindividual and intraindividual variability, and that these assays are not standardized and lack an accepted reference range [1]. That statement is made in the context of dosing hormone therapy; this record extrapolates the same assay-reliability concerns (lack of standardization, no validated reference range) to using the panel diagnostically, which is reasoned but was not itself the subject of a dedicated study located this session (see evidence_notes). Reporting five or more hormones at once can generate multiple borderline or out-of-range results with no validated pathway to act on them, prompting supplementation or anxiety.

Better first step

Use the standard, validated serum assay for the specific hormone in question (see the estradiol, progesterone, Testosterone (total and free), women, and Testosterone (total, and free/bioavailable), men entries), timed appropriately to the menstrual cycle where relevant.

Typical ND rationale

An ND may order a salivary panel covering several sex hormones and DHEA at once, reasoning that saliva reflects the free, bioavailable fraction of a hormone, that a broader panel gives a fuller picture than a single blood test, and that home collection is more convenient for the patient.

Ontario coverage & CONO orderability

OHIP status

unverified

This is a branded, multi-analyte send-out panel, not a line item in the 2026 Schedule of Benefits for Laboratory Services; it is sold and collected directly through naturopathic and specialty-lab channels rather than billed to OHIP. ND-ordered testing of this kind is patient-paid [3, 4, 2].

CONO orderable

Yes — CONO list #169, #170, #172, #174, #175, #176, #177, #178, #179, #181, #182, #183

Not listed as a panel. Its component sex-hormone-related analytes are on the CONO saliva list: 17-OH-progesterone (169), DHT (170), androstenedione (172), DHEAS (174), esterol (175), estradiol (176), estriol (177), estrogen (178), estrone (179), progesterone (181), testosterone (182), testosterone free (183); Ontario ND clinics offer these panels [2]. Saliva cortisol (173) and melatonin (180) are also on the CONO saliva list but are addressed under the adrenal batch's Diurnal salivary cortisol panel (4-point / "adrenal stress") and melatonin entries, not repeated here.

Linked conditions

• menopause ↗
• "Estrogen dominance" / "progesterone deficiency" ↗

Counselling script

“This saliva panel checks several hormones at once, but the testing isn't standardized between labs and there's no agreed range to compare your result to, so I can't reliably act on an abnormal result from it. Let's use the specific, well-studied blood test that matches what you're actually experiencing instead, and go from there.”

Revisit if

• —Symptoms suggest a specific hormone deficiency or excess worth targeted serum testing
• —Perimenopausal or menopausal symptoms warrant clinical assessment (not panel-based diagnosis)

References

1. [1]The Menopause Society (NAMS) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. linkSalivary and urine hormone testing to determine dosing are unreliable and not recommended; salivary assays are not standardized and lack an accepted reference range
2. [2]naturopathtoronto.ca (2026). Lab Tests | Hormones | Thyroid | Food Allergies | Naturopath. linkExample of an Ontario ND clinic offering salivary hormone panels directly to patients
3. [3]Government of Ontario (e-Laws) (2026). Health Insurance Act, R.R.O. 1990, Reg. 552: General, s. 22 (insured laboratory services). linkA lab test is insured only when ordered by a physician, midwife, or NP who has clinically assessed the patient
4. [4]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkTests ordered by anyone other than an authorized provider, including NDs, are not insured services